Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Life Science History - Page 41

Life Science History

Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood test
COVID-19 | Life Science History | Vaccine

Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood test

On Dec. 15, 2020, Abbott announced it received had CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin…

Read More Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood testContinue

FDA authorized antigen test as first over-the-counter fully at-home diagnostic test for COVID-19
COVID-19 | FDA | Life Science History

FDA authorized antigen test as first over-the-counter fully at-home diagnostic test for COVID-19

On Dec. 15, 2020, the FDA granted emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home…

Read More FDA authorized antigen test as first over-the-counter fully at-home diagnostic test for COVID-19Continue

TGen identified gene that could explain disparity in COVID-19 effects
COVID-19 | Life Science History

TGen identified gene that could explain disparity in COVID-19 effects

On Dec. 15, 2020, TGen, an affiliate of City of Hope announced that it had identified a specific…

Read More TGen identified gene that could explain disparity in COVID-19 effectsContinue

Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacity
COVID-19 | Life Science History

Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacity

On Dec. 15, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…

Read More Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacityContinue

Antibody study suggested COVID-19 infections underestimated
COVID-19 | Life Science History

Antibody study suggested COVID-19 infections underestimated

On Dec. 14, 2020, a months long study to determine the number of Houstonians carrying COVID-19 antibodies revealed…

Read More Antibody study suggested COVID-19 infections underestimatedContinue

FDA approved first intentional genomic alteration in domestic pigs for both human food, potential therapeutic uses
FDA | Life Science History

FDA approved first intentional genomic alteration in domestic pigs for both human food, potential therapeutic uses

On Dec. 14, 2020, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in…

Read More FDA approved first intentional genomic alteration in domestic pigs for both human food, potential therapeutic usesContinue

FDA approved first-of-its-kind Intentional genomic alteration in Line of domestic pigs for human food, potential therapeutic uses
FDA | Life Science History

FDA approved first-of-its-kind Intentional genomic alteration in Line of domestic pigs for human food, potential therapeutic uses

On Dec. 14, 2020, the U.S. Food and Drug Administration (FDA) approved the a first-of-its-kind intentional genomic alteration…

Read More FDA approved first-of-its-kind Intentional genomic alteration in Line of domestic pigs for human food, potential therapeutic usesContinue

CureVac commenced global pivotal phase 2b/3 trial for COVID-19 vaccine candidate, CVnCoV
COVID-19 | Life Science History | Vaccine

CureVac commenced global pivotal phase 2b/3 trial for COVID-19 vaccine candidate, CVnCoV

On Dec. 14, 2020, CureVac announced that it had enrolled the first participant in the pivotal Phase 2b/3…

Read More CureVac commenced global pivotal phase 2b/3 trial for COVID-19 vaccine candidate, CVnCoVContinue

Novartis updated on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19
COVID-19 | Life Science History

Novartis updated on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19

On Dec. 14, 2020, Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard…

Read More Novartis updated on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19Continue

No association found between COVID-19 and Guillain-Barre syndrome
COVID-19 | Life Science History | Neurology

No association found between COVID-19 and Guillain-Barre syndrome

On Dec.14, 2020, neuroscientists at University College London (UCL) announced they had found no significant association between COVID-19…

Read More No association found between COVID-19 and Guillain-Barre syndromeContinue

U.S. Dept of Veterans Affairs began COVID-19 vaccinations
COVID-19 | Life Science History | Vaccine

U.S. Dept of Veterans Affairs began COVID-19 vaccinations

On Dec. 14, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that the New Orleans and Bedford,…

Read More U.S. Dept of Veterans Affairs began COVID-19 vaccinationsContinue

Codagenix and Serum Institute commenced first-in-human trial of COVI-VAC single dose, intranasal COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Codagenix and Serum Institute commenced first-in-human trial of COVI-VAC single dose, intranasal COVID-19 vaccine

On Dec. 14, 2020, Codagenix and the Serum Institute of India announced that a Phase 1 clinical trial…

Read More Codagenix and Serum Institute commenced first-in-human trial of COVI-VAC single dose, intranasal COVID-19 vaccineContinue

Data from phase 1/2 study further characterized immune response with lead COVID-19 vaccine candidate
Life Science History

Data from phase 1/2 study further characterized immune response with lead COVID-19 vaccine candidate

On Dec. 14, 2020, Pfizer and BioNTech announced additional data on neutralizing antibody and T cell responses from…

Read More Data from phase 1/2 study further characterized immune response with lead COVID-19 vaccine candidateContinue

AstraZeneca acquired Alexion Corp for $39 billion
Life Science History

AstraZeneca acquired Alexion Corp for $39 billion

On Dec. 12, 2020, AstraZeneca and Alexion Pharmaceuticals announced an agreement for AstraZeneca to acquire Alexion. Alexion shareholders…

Read More AstraZeneca acquired Alexion Corp for $39 billionContinue

Amarin reported encouraging efficacy and safety results from VASCEPA pilot study treating COVID-19 infected outpatients
COVID-19 | EPA | Life Science History

Amarin reported encouraging efficacy and safety results from VASCEPA pilot study treating COVID-19 infected outpatients

On Dec. 12, 2020, Amarin announced clinical results from the CardioLink-9 Trial, the first results of a study…

Read More Amarin reported encouraging efficacy and safety results from VASCEPA pilot study treating COVID-19 infected outpatientsContinue

CDC recommended vaccination with Pfizer and BioNTech COVID-19 vaccine for ages 16 years and older
CDC | COVID-19 | Life Science History

CDC recommended vaccination with Pfizer and BioNTech COVID-19 vaccine for ages 16 years and older

On Dec. 12, 2020, Pfizer and BioNTech announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) voted…

Read More CDC recommended vaccination with Pfizer and BioNTech COVID-19 vaccine for ages 16 years and olderContinue

US FDA issued Emergency Use Authorization for first COVID-19 vaccine
COVID-19 | FDA | Life Science History

US FDA issued Emergency Use Authorization for first COVID-19 vaccine

On Dec. 11, 2020, the FDA issued the first emergency use authorization (EUA) for a vaccine for the…

Read More US FDA issued Emergency Use Authorization for first COVID-19 vaccineContinue

Baricitinib plus remdesivir showed promise for treating COVID-19
COVID-19 | Life Science History

Baricitinib plus remdesivir showed promise for treating COVID-19

On Dec. 11, 2020, the combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to…

Read More Baricitinib plus remdesivir showed promise for treating COVID-19Continue

USDA confirmed COVID-19 in a snow leopard at a Kentucky zoo
COVID-19 | Life Science History | USDA | Veterinary

USDA confirmed COVID-19 in a snow leopard at a Kentucky zoo

On Dec. 11, 2020, the USDA’s National Veterinary Services Laboratories announced the first confirmed case of SARS-CoV-2 (the…

Read More USDA confirmed COVID-19 in a snow leopard at a Kentucky zooContinue

US Dept of Veterans Affairs announced initial plans for COVID-19 vaccine distribution
COVID-19 | FDA | Life Science History

US Dept of Veterans Affairs announced initial plans for COVID-19 vaccine distribution

On Dec. 10, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a preliminary plan for distributing COVID-19…

Read More US Dept of Veterans Affairs announced initial plans for COVID-19 vaccine distributionContinue

European CHMP adopted positive opinion for HEPLISAV-Bᆴ hepatitis B adjuvanted vaccine
Life Science History

European CHMP adopted positive opinion for HEPLISAV-Bᆴ hepatitis B adjuvanted vaccine

On Dec. 10, 2020, Dynavax Technologies announced that the European Medicines Agency (EMA) Committee for Medicinal Products for…

Read More European CHMP adopted positive opinion for HEPLISAV-Bᆴ hepatitis B adjuvanted vaccineContinue

Pfizer and BioNTech received FDA Advisory Committee vote supporting EUA for COVID-19 vaccine in the US
COVID-19 | FDA | Life Science History

Pfizer and BioNTech received FDA Advisory Committee vote supporting EUA for COVID-19 vaccine in the US

On Dec. 10, 2020, Pfizer and BioNTech announced that the FDA Vaccines and Related Biological Products Advisory Committee…

Read More Pfizer and BioNTech received FDA Advisory Committee vote supporting EUA for COVID-19 vaccine in the USContinue

LabCorp received FDA Authorization to make at-home COVID-19 collection kits available rhrough retail
COVID-19 | FDA | Life Science History

LabCorp received FDA Authorization to make at-home COVID-19 collection kits available rhrough retail

On Dec. 9, 2020, LabCorp announced that the FDA had granted Emergency Use Authorization (EUA) for the Pixel…

Read More LabCorp received FDA Authorization to make at-home COVID-19 collection kits available rhrough retailContinue

Virologist Michael Houghton awarded Nobel Prize in Physiology or Medicine for the discovery of Hepatitis C virus
Life Science History

Virologist Michael Houghton awarded Nobel Prize in Physiology or Medicine for the discovery of Hepatitis C virus

On Dec. 8, 2020, University of Alberta virologist Michael Houghton was awarded a share of the 2020 Nobel…

Read More Virologist Michael Houghton awarded Nobel Prize in Physiology or Medicine for the discovery of Hepatitis C virusContinue

First peer-reviewed results of phase 3 human trials of University of Oxford vaccine demonstrated efficacy
Life Science History | Vaccine

First peer-reviewed results of phase 3 human trials of University of Oxford vaccine demonstrated efficacy

On Dev. 8, 2020, University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials…

Read More First peer-reviewed results of phase 3 human trials of University of Oxford vaccine demonstrated efficacyContinue

FDA accepted for priority review the BLA for Pfizerメs investigational 20-valent pneumococcal conjugate vaccine
FDA | Life Science History

FDA accepted for priority review the BLA for Pfizerメs investigational 20-valent pneumococcal conjugate vaccine

On Dec. 8, 2020, Pfizer announced that the FDA accepted for priority review a Biologics License Application (BLA)…

Read More FDA accepted for priority review the BLA for Pfizerメs investigational 20-valent pneumococcal conjugate vaccineContinue

Serum Institute applied for emergency use authorisation for COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Serum Institute applied for emergency use authorisation for COVID-19 vaccine

On Dec. 7, 2020, the Serum Institute of India (SII) announced that it had applied to Drugs Controller…

Read More Serum Institute applied for emergency use authorisation for COVID-19 vaccineContinue

Chimerix announced FDA acceptance of NDA for brincidofovir as a medical countermeasure for smallpox
FDA | Life Science History

Chimerix announced FDA acceptance of NDA for brincidofovir as a medical countermeasure for smallpox

On Dec. 7, 2020, Chimerix announced that the FDA has accepted the filing of a New Drug Application…

Read More Chimerix announced FDA acceptance of NDA for brincidofovir as a medical countermeasure for smallpoxContinue

Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma resist chemotherapy
Life Science History

Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma resist chemotherapy

On Dec. 5, 2020, Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma…

Read More Dr. James Lim and Lakshana Sreenivasan discovered that certain immune signals may help medulloblastoma resist chemotherapyContinue

NIH researchers linked cases of ALS and FTD to a mutation associated with Huntingtonメs disease
Life Science History

NIH researchers linked cases of ALS and FTD to a mutation associated with Huntingtonメs disease

On Dec. 4, 2020, researchers at the National Institutes of Health reported that they had made a surprising…

Read More NIH researchers linked cases of ALS and FTD to a mutation associated with Huntingtonメs diseaseContinue

Page navigation

Previous PagePrevious 1 … 39 40 41 42 43 … 168 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search